GALDY regulatory event: an FDA approval, +0.9%

On February 12, 2025, Galderma Group AG/ADR reached its regulatory event. The result was an FDA approval, and the stock moved +0.9% in the window around the event. It had already run +17.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.